Multilab Indústria e Comércio de Produtos Farma

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

In a reversal of a past acquisition, Takeda Pharmaceutical Co. Ltd. is to fully divest all its shares and assets in Multilab Indústria e Comércio de Produtos Farma in Brazil to Novamed, part of th

TOKYO – The stark contrast between Takeda Pharmaceutical Co. Ltd. pre- and post-Nycomed were evident in first quarter earnings as the Japanese firm becomes more entrenched in emerging markets. In

TOKYO – Takeda Pharmaceutical Co. Ltd. fell far short of its financial year guidance and forecasts for the next year disappointed analysts. The dismal figures were attributed to higher-than-expect